In Vitro Diagnostics Business Outlook: Volume 1, Issue 6 - Coagulation Testing
12 Jan 2022
Categories:
In Vitro Diagnostics Business Outlook
A new twice-monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook offers the following:
• Market Sizing and Forecasting of IVD Market Segments in Every Issue
• Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About
• Industry Watch – Developments with COVID-19 and Other Testing
• M&A, Distribution, Partnerships Tracked and Charted
• New Product Introductions and Company Announcements
• Company Profiling and Quarterly Results Summaries
• Regional Market Coverage
Table of Contents
-
Market Analysis: Focus on Coagulation Testing
- Overview of Diagnostics in Coagulation
-
Market Outlook
- Major Product Activity
- Laboratory vs. Point-of-Care Markets
- Regional Market
-
Top Company Briefs
- Roche
- Sysmex
- Werfen
-
Executive News Briefing
- Bio-Techne Appoints New President of Protein Sciences Segment
- Mainz BioMed Appoints New VP of Regulatory Affairs
- Lifespin GmbH Secures Financing
- Numares Appoints New Member to Supervisory Board
- Predicine Appoints New CFO
-
Financial Highlights: Agilent, Myriad Genetics and OraSure Technologies
- Agilent Reports ‘Record-Setting Performance’ in Fiscal 2021
- Myriad Genetics Reports 15% Growth in Third Quarter 2021
- OraSure Technologies Focuses on InteliSwab Growth for FY22
-
Diagnostic Market Mergers, Acquisitions and Partnership Deals
- Mergers and Acquisitions
- Partnerships and Collaborations
-
Industry Watch
- COVID-19 Update
-
Region Watch
- Canada
- France
- Vietnam
-
Broad-based Company Announcements
- Labcorp
- Quidel
- NGeneBio